146 related articles for article (PubMed ID: 5676035)
1. Effect of different dopa decarboxylase inhibitors on the hypotensive response to alpha-methyldopa in rats.
Henning M
Br J Pharmacol; 1968 Sep; 34(1):233P-234P. PubMed ID: 5676035
[No Abstract] [Full Text] [Related]
2. Studies on the mode of action of alpha-methyldopa.
Henning M
Acta Physiol Scand Suppl; 1969; 322():1-37. PubMed ID: 4311985
[No Abstract] [Full Text] [Related]
3. Interaction of DOPA decarboxylase inhibitors with the effect of alpha-methyldopa on blood pressure and tissue monoamines in rats.
Henning M
Acta Pharmacol Toxicol (Copenh); 1969; 27(2):135-48. PubMed ID: 5819569
[No Abstract] [Full Text] [Related]
4. Modification of the cardiovascular effects of L-dopa by decarboxylase inhibitors.
Watanabe AM; Parks LC; Kopin IJ
J Clin Invest; 1971 Jun; 50(6):1322-8. PubMed ID: 5578236
[TBL] [Abstract][Full Text] [Related]
5. Aromatic amino acid decarboxylase inhibitors.
Porter CC
Fed Proc; 1971; 30(3):871-6. PubMed ID: 5575298
[No Abstract] [Full Text] [Related]
6. [Relationship between the antihypertensive activity of methyldopa and the appearance of its metabolites in the heart and brain of the hypertensive rat].
Cohen Y; Wepierre J; Jacquot C; Rapin J
Arch Int Pharmacodyn Ther; 1974 Feb; 207(2):348-60. PubMed ID: 4827419
[No Abstract] [Full Text] [Related]
7. The mode of action of -methyldopa.
Day MD; Roach AG; Whiting RL
Br J Pharmacol; 1972 May; 45(1):168P-169P. PubMed ID: 5041485
[No Abstract] [Full Text] [Related]
8. Urinary excretion of noradrenaline after treatment with alpha-methyldopa: inhibition by a central nervous mechanism.
Andén NE; Henning M
Acta Physiol Scand; 1974 Jan; 90(1):69-72. PubMed ID: 4814544
[No Abstract] [Full Text] [Related]
9. [Inhibitors of catecholamine biosynthesis (review of the literature)].
Frantsuzova SB
Farmakol Toksikol; 1973; 36(5):624-8. PubMed ID: 4150865
[No Abstract] [Full Text] [Related]
10. Comparison of centrally mediated hypotensive action of methyldopa and DOPA in cats.
Torchiana ML; Lotti VJ; Clark CM; Stone CA
Arch Int Pharmacodyn Ther; 1973 Sep; 205(1):103-13. PubMed ID: 4148405
[No Abstract] [Full Text] [Related]
11. Cerebral accumulation and metabolism of C14-dopa after selective inhibition of peripheral decarboxylase.
Bartholini G; Pletscher A
J Pharmacol Exp Ther; 1968 May; 161(1):14-20. PubMed ID: 5648492
[No Abstract] [Full Text] [Related]
12. Inhibition of dopa decarboxylation by RO4-4602, MK 485 and MK 486 in human liver homogenates.
Vogel WH; Mahoney K; Hare TA
Arch Int Pharmacodyn Ther; 1972; 198(1):85-93. PubMed ID: 4538242
[No Abstract] [Full Text] [Related]
13. [Pharmacological and biochemical effects of hydralazine and dihydralazine].
van Zwieten PA
Arzneimittelforschung; 1968 Jan; 18(1):79-84. PubMed ID: 4386976
[No Abstract] [Full Text] [Related]
14. Reduction of aromatic L-amino acid decarboxylase protein in rats after chronic administration of alpha-methyldopa.
Culvenor AJ; Jarrott B
Mol Pharmacol; 1979 Jan; 15(1):86-98. PubMed ID: 106235
[No Abstract] [Full Text] [Related]
15. 3-Hydrazinopyridazine derivatives as inhibitors of pyridoxal-phosphate dependent enzymes.
Buffoni F; Carpi C; Banchelli Soldaini G; Raimondi L
Farmaco Sci; 1980 Oct; 35(10):848-55. PubMed ID: 6778712
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of hydrazines on brain decarboxylases.
de Ropp RS; Furst A
Proc West Pharmacol Soc; 1967; 10():23-5. PubMed ID: 6055497
[No Abstract] [Full Text] [Related]
17. On the localization of the hypotensive effect of L-dopa.
Henning M; Rubenson A; Trolin G
J Pharm Pharmacol; 1972 Jun; 24(6):447-51. PubMed ID: 4403826
[No Abstract] [Full Text] [Related]
18. Potentiation and inhbition of some central actions of L(-)-dopa by decarboxylase inhibitors.
Lotti VJ; Porter CC
J Pharmacol Exp Ther; 1970 Apr; 172(2):406-15. PubMed ID: 5441162
[No Abstract] [Full Text] [Related]
19. [Variations in the catecholamine content of the rat brain and heart after administration of alpha-methyldopa, clonidine and diazoxide].
Albano V; Bellanca L; Latteri S; Valdes L
Boll Soc Ital Biol Sper; 1977 Nov; 53(22):2036-40. PubMed ID: 603708
[No Abstract] [Full Text] [Related]
20. Effect of alpha-methyl dopa on the reserpine-induced suppression of motor activity and the conditioned avoidance response.
Uretsky NJ; Seiden LS
J Pharmacol Exp Ther; 1969 Jul; 168(1):153-62. PubMed ID: 4307318
[No Abstract] [Full Text] [Related]
[Next] [New Search]
